Back

T-wave alternans poorly prognostic in primary prophylactic ICD patients: A prospective EU-CERT-ICD study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Primary arrhythmia syndromes - Device treatment Device Treatment ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Mr Ari Pelli

Medical Research Center Oulu, Oulu (Finland)

3 More presentations in this session

Presentation thumbnail
Three dimensional modelling of mutant Kir2.1 channel PIP2 interactions help stratify arrhythmia severity in Andersen Tawil syndrome type 1
Mrs L. Gutierrez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Characteristics and prognosis of the catecholamine induced QT prolongation syndrome
Professor V. Probst (Nantes, FR)
Abstract Slides Video
Presentation thumbnail
Catecholaminergic polymorphic ventricular tachycardia: risk modulators in patients treated with beta-blockers
Doctor D. Kukavica (Pavia, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Primary arrhythmia syndromes - Device treatment

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation/flutter may modify the long-term effect of primary prevention implantable cardioverter-defibrillators in non-ischemic HFrEF: an extended follow-up study of the DANISH trial
thumbnail
Congress Presentation
Competing risks of ventricular tachyarrhythmias and mortality in advanced heart failure: impact of left ventricular ejection fraction
thumbnail
Congress Presentation
Ablation should be performed prophylactically in post-myocardial infarction patients eligible for primary prevention ICD implantation: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources